SEC Info  
  Home     Search     My Interests     Help     Sign In     Please Sign In  

Sierra Health Services Inc · DEFM14A · On 5/21/07

Filed On 5/21/07 5:30pm ET   ·   SEC File 1-08865   ·   Accession Number 1104659-7-41854

  in   Show  and 
  As Of               Filer                 Filing     As/For/On Docs:Pgs              Issuer               Agent

 5/21/07  Sierra Health Services Inc        DEFM14A     5/21/07    1:208                                    Merrill Corp-MD/FA

Definitive Proxy Solicitation Material -- Merger or Acquisition   ·   Schedule 14A
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: DEFM14A     Prem14a                                             HTML  1,105K 


Document Table of Contents

Page (sequential) | (alphabetic) Top
 
11st Page
"Questions and Answers About the Special Meeting and the Merger
"Summary Term Sheet
"The Parties to the Merger
"The Merger Agreement and the Merger
"The Voting and Support Agreement
"Timing and Likelihood of Closing
"Per Share Merger Consideration
"Board of Directors Recommendation
"Opinion of Lehman Brothers
"Record Date and Voting Power
"Stockholder Vote Required to Approve the Merger Agreement
"Material United States Federal Income Tax Consequences
"Dissenters Rights
"Share Ownership of Directors and Certain Beneficial Owners
"Interests of the Company s Directors, Executive Officers and Certain Beneficial Owners in the Merger
"Company Takeover Proposals; Company Superior Proposals
"Regulatory Approvals
"Conditions to Closing
"Termination of the Merger Agreement
"Termination Fees
"Procedure for Receiving the Per Share Merger Consideration
"Market Prices of the Company s Common Stock
"Cautionary Statement Concerning Forward-Looking Information
"Sierra Health Services, Inc
"UnitedHealth Group Incorporated
"Sapphire Acquisition, Inc
"The Special Meeting
"Time, Place and Purpose of the Special Meeting
"Record Date, Quorum and Voting Power
"Required Vote
"Voting by Directors, Executive Officers and Certain Record Holders
"Proxies; Revocation
"Expenses of Proxy Solicitation
"Adjournments
"The Merger
"Background of the Merger
"Reasons for the Merger
"Recommendation of the Board of Directors
"Certain Effects of the Merger
"Effects on the Company and Our Stockholders If the Merger Is Not Completed
"Effects of the Merger on Our Senior Convertible Debentures
"Stock Options and Restricted Stock Units
"Employee Stock Purchase Plan
"Employment Agreements and Other Arrangements
"Project Pay Plan
"Director and Officer Indemnification and Insurance
"Indemnity Agreements
"Section 16 Matters
"The Merger Agreement
"General
"Effective Time
"Conversion of Shares
"Exchange and Payment Procedures
"Articles of Incorporation and Bylaws
"Directors and Officers
"Representations and Warranties
"Material Adverse Effect
"Covenants of the Parties
"Conditions to Closing the Merger
"Company Termination Fee
"UnitedHealth Group Termination Fee
"Amendment and Waiver
"Market Prices of the Company S Common Stock and Dividend Data
"Security Ownership of Certain Beneficial Owners and Management
"Stockholder Proposals for Our 2007 Annual Meeting
"Other Matters
"Other Business at the Special Meeting
"Where You Can Find Additional Information

This is an EDGAR HTML document rendered as filed.  [ Alternative Formats ]


 UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 14A

Proxy Statement Pursuant to Section 14(a) of
the Securities Exchange Act of 1934

Filed by the Registrant  x

Filed by a Party other than the Registrant  o

Check the appropriate box:

o

Preliminary Proxy Statement

o

Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))

x

Definitive Proxy Statement

o

Definitive Additional Materials

o

Soliciting Material Pursuant to §240.14a-12

 

SIERRA HEALTH SERVICES, INC.

(Name of Registrant as Specified In Its Charter)

 

(Name of Person(s) Filing Proxy Statement, if other than the Registrant)

 

Payment of Filing Fee (Check the appropriate box):

o

No fee required.

o

Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.

 

(1)

Title of each class of securities to which transaction applies:

 

 

 

 

(2)

Aggregate number of securities to which transaction applies:

 

 

 

 

(3)

Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):

 

 

 

 

(4)

Proposed maximum aggregate value of transaction:

 

 

 

 

(5)

Total fee paid:

 

 

 

x

Fee paid previously with preliminary materials.

o

Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.

 

(1)

Amount Previously Paid:

 

(2)

Form, Schedule or Registration Statement No.:

 

(3)

Filing Party:

 

(4)

Date Filed:

 




Image -- GRAPHIC

Sierra Health Services, Inc
2724 North Tenaya Way
Las Vegas, Nevada 89128

May 21, 2007

Dear Stockholder:

I am pleased to inform you that Sierra Health Services, Inc. and UnitedHealth Group Incorporated have entered into a definitive merger agreement pursuant to which UnitedHealth Group will acquire all of the outstanding shares of the Company’s common stock. If the merger is completed, the Company will become wholly owned by UnitedHealth Group and you will receive $43.50 in cash for each of your shares of our common stock. The $43.50 per share merger consideration represents a premium of approximately 21.2% over the closing price of $35.90 per share of our common stock on March 9, 2007, the last trading day prior to the announcement of the merger.

You are cordially invited to attend a special meeting of our stockholders to be held on Wednesday, June 27, 2007, at 1:00 p.m., Pacific Daylight Time, in the Chairman’s Auditorium at the Sierra Health Services corporate complex, 2716 North Tenaya Way, Las Vegas, Nevada, to vote on the approval of the merger agreement. As described in the enclosed proxy statement, the Company’s board of directors has unanimously adopted the merger agreement and declared that the merger and the merger agreement are advisable and in the best interests of the Company and its stockholders. The Company’s board of directors recommends that you vote “FOR” the approval of the merger agreement.

The Company cannot complete the merger unless the Company’s stockholders approve the merger agreement. Such approval requires the affirmative vote by the holders of a majority of the shares of our common stock outstanding on the record date. In connection with the Company entering into the merger agreement, I have agreed, in my capacity as a stockholder, to vote the shares of common stock I beneficially own (other than any shares of common stock as to which I act in a fiduciary capacity on behalf of persons other than members of my family), which shares represent approximately 8.0% of the outstanding shares of the Company’s common stock, in favor of the approval of the merger agreement.

The notice of special meeting and the proxy statement that accompanies this letter provide you with extensive information about the merger agreement, the merger and the special meeting. We encourage you to read these materials carefully. You may also obtain more detailed information about the Company from documents that we have filed with the Securities and Exchange Commission.

Your vote is important. Whether or not you plan to attend the special meeting, please read the enclosed proxy statement and promptly complete, sign, date and return the enclosed proxy card in the postage-paid envelope provided or submit a proxy through the Internet or by telephone in accordance with the directions set forth on the proxy card. Your shares will then be represented at the special meeting. If you attend the special meeting, you may, by following the procedures discussed in the accompanying documents, vote in person notwithstanding the fact that you may have previously submitted a proxy. Thank you for your continued support.

Sincerely,

 

Image -- GRAPHIC

 

Anthony M. Marlon, M.D.

 

Chairman of the Board of Directors and

 

Chief Executive Officer

 

This transaction has not been approved or disapproved by the Securities and Exchange Commission, nor has the Securities and Exchange Commission passed upon the fairness or merits of this transaction or the accuracy or adequacy of the information contained in this proxy statement. Any representation to the contrary is unlawful.

This proxy statement is dated May 21, 2007, and is first being mailed, along with the attached proxy card, to stockholders of the Company on or about May 22, 2007.




Image -- GRAPHIC

NOTICE OF SPECIAL MEETING OF STOCKHOLDERS
To Be Held on June 27
, 2007 

To the Stockholders:

A special meeting of stockholders of Sierra Health Services, Inc. will be held on Wednesday, June 27, 2007, at 1:00 p.m., Pacific Daylight Time, in the Chairman’s Auditorium at the Sierra Health Services corporate complex, 2716 North Tenaya Way, Las Vegas, Nevada, for the following purposes:

1.                to consider and vote on the proposal to approve the Agreement and Plan of Merger, dated as of March 11, 2007, by and among UnitedHealth Group Incorporated (“UnitedHealth Group”), Sapphire Acquisition, Inc. (“Merger Sub”) and Sierra Health Services, Inc. (the “Company”), pursuant to which Merger Sub will be merged with and into the Company and the Company will become an indirect wholly-owned subsidiary of UnitedHealth Group (the “Merger”); and

2.                to transact any other business as may properly come before the special meeting or at any adjournment of the special meeting.

The Company’s board of directors has determined that the merger agreement and the merger are advisable to and in the best interests of the Company and its stockholders and has unanimously adopted the merger agreement, the merger and the other transactions contemplated by the merger agreement. If the merger is completed, each issued and outstanding share of our common stock will be converted into the right to receive $43.50 in cash, without interest. Under Nevada law, no dissenters’ rights or rights of appraisal will apply in connection with the merger.

The merger is described in the accompanying proxy statement, which you are urged to read carefully. A copy of the merger agreement is attached to the proxy statement as Appendix A.

The Company’s board of directors has fixed the close of business on May 18, 2007, as the record date for the determination of stockholders entitled to notice of and to vote at the special meeting. Accordingly, only stockholders of record on that date are entitled to vote at the special meeting or any adjournments thereof. A list of stockholders entitled to vote at the special meeting will be open for inspection by any stockholder at any time during usual business hours for a period of 5 days prior to the special meeting at the offices of the Company, 2724 North Tenaya Way, Las Vegas, Nevada 89128.

Approval of the merger agreement requires the affirmative vote by the holders of a majority of the shares of our common stock outstanding on the record date in accordance with Nevada law, our restated articles of incorporation and our amended and restated bylaws. Under the terms of a voting and support agreement (which will terminate upon the termination of the merger agreement), Anthony M. Marlon, M.D., the Chairman of our board of directors and our Chief Executive Officer, has agreed to vote the shares of our common stock he beneficially owns (other than any shares of our common stock as to which Dr. Marlon acts in a fiduciary capacity on behalf of persons other than members of his family) in favor of the approval of the merger agreement. Such shares represent approximately 8.0% of the outstanding shares of our common stock.

The board of directors is not aware of any matters that may be brought before the special meeting other than those set forth in this Notice of Special Meeting of Stockholders. If other matters properly come before the special meeting, the persons named in the accompanying proxy card will vote the shares represented by all properly submitted proxies on such matters in accordance with any recommendation of the board of directors or, in the absence of such recommendation, in their discretion.




Whether or not you plan to attend the special meeting in person, please complete, sign, date and return the enclosed proxy card in the postage-paid envelope provided or submit a proxy through the Internet or by telephone, in accordance with the directions set forth on the proxy card, to ensure that your shares will be represented at the special meeting. If you do attend the special meeting and wish to vote in person, you may do so notwithstanding the fact that you previously submitted a proxy. Please note, however, that if your shares are held of record by a broker, bank or other nominee and you wish to vote at the meeting, you must obtain from your nominee a proxy issued in your name.

Please do not send your stock certificates at this time. If the merger is completed, you will be sent instructions regarding the surrender of your stock certificates.

The board of directors has unanimously adopted the merger agreement and recommends that our stockholders vote “FOR” the approval of the merger agreement.

 

By Order of the Board of Directors,

 

Image -- GRAPHIC

 

Frank E. Collins

 

Secretary

 

Las Vegas, Nevada
May 21
, 2007




PROXY STATEMENT
TABLE OF CONTENTS 

 

Page

 

QUESTIONS AND ANSWERS ABOUT THE SPECIAL MEETING AND THE MERGER

 

 

1

 

 

SUMMARY TERM SHEET

 

 

6

 

 

The Parties to the Merger

 

 

6

 

 

The Merger Agreement and the Merger

 

 

6

 

 

The Voting and Support Agreement

 

 

6

 

 

Timing and Likelihood of Closing

 

 

6

 

 

Per Share Merger Consideration

 

 

7

 

 

Board of Directors Recommendation

 

 

7

 

 

Opinion of Lehman Brothers

 

 

7

 

 

Record Date and Voting Power

 

 

7

 

 

Stockholder Vote Required to Approve the Merger Agreement

 

 

7

 

 

Material United States Federal Income Tax Consequences

 

 

8

 

 

Dissenters’ Rights

 

 

8

 

 

Share Ownership of Directors and Certain Beneficial Owners

 

 

8

 

 

Interests of the Company’s Directors, Executive Officers and Certain Beneficial Owners in the Merger

 

 

8

 

 

Company Takeover Proposals; Company Superior Proposals

 

 

9

 

 

Regulatory Approvals

 

 

10

 

 

Conditions to Closing

 

 

10

 

 

Termination of the Merger Agreement

 

 

11

 

 

Termination Fees

 

 

11

 

 

Procedure for Receiving the Per Share Merger Consideration

 

 

12

 

 

Market Prices of the Company’s Common Stock

 

 

12

 

 

CAUTIONARY STATEMENT CONCERNING FORWARD-LOOKING INFORMATION

 

 

13

 

 

THE PARTIES TO THE MERGER

 

 

14

 

 

Sierra Health Services, Inc.

 

 

14

 

 

UnitedHealth Group Incorporated.

 

 

14

 

 

Sapphire Acquisition, Inc.

 

 

14

 

 

THE SPECIAL MEETING

 

 

14

 

 

Time, Place and Purpose of the Special Meeting

 

 

14

 

 

Record Date, Quorum and Voting Power

 

 

15

 

 

Required Vote

 

 

15

 

 

Voting by Directors, Executive Officers and Certain Record Holders

 

 

16

 

 

Proxies; Revocation

 

 

16

 

 

Expenses of Proxy Solicitation

 

 

17

 

 

Adjournments

 

 

17

 

 

THE MERGER

 

 

17

 

 

Background of the Merger

 

 

17

 

 

Reasons for the Merger

 

 

24

 

 

Recommendation of the Board of Directors

 

 

26

 

 

Opinion of Lehman Brothers

 

 

26

 

 

Certain Effects of the Merger

 

 

32

 

 

Effects on the Company and Our Stockholders If the Merger Is Not Completed

 

 

33

 

 

Effects of the Merger on Our Senior Convertible Debentures

 

 

33

 

 

i




 

Interests of the Company’s Directors, Executive Officers and Certain Beneficial Owners in the Merger

 

 

34

 

 

Stock Options and Restricted Stock Units

 

 

34

 

 

Employee Stock Purchase Plan

 

 

36

 

 

Employment Agreements and Other Arrangements

 

 

37

 

 

Project Pay Plan

 

 

41

 

 

Director and Officer Indemnification and Insurance

 

 

41

 

 

Indemnity Agreements

 

 

41

 

 

Section 16 Matters

 

 

42

 

 

Material United States Federal Income Tax Consequences

 

 

42

 

 

Regulatory Approvals

 

 

43

 

 

THE MERGER AGREEMENT

 

 

44

 

 

General

 

 

45

 

 

Effective Time

 

 

45

 

 

Per Share Merger Consideration

 

 

45

 

 

Conversion of Shares

 

 

45